Haemonetics HAE Income Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $346.35M+2.2% | $338.97M+3.6% | $327.32M+1.8% | $321.39M-2.8% | $330.6M-5.1% | ||
| $148.14M+8.5% | $136.58M+3.0% | $132.57M+2.6% | $129.15M-6.1% | $137.55M-11.3% | ||
| $198.21M-2.1% | $202.39M+3.9% | $194.74M+1.3% | $192.24M-0.4% | $193.05M-0.3% | ||
| 57.2%-2.5pp | 59.7%+0.2pp | 59.5%-0.3pp | 59.8%+1.4pp | 58.4%+2.9pp | ||
| $14.45M+1.8% | $14.19M-4.6% | $14.87M-8.5% | $16.26M-11.2% | $18.31M+15.6% | ||
| $120.93M+10.8% | $109.15M+7.4% | $101.62M-8.2% | $110.72M-3.8% | $115.14M+8.2% | ||
| $221.24M+63.9% | $134.99M-0.9% | $136.25M-1.5% | $138.37M+13.7% | $121.72M-9.5% | ||
| —— | $67.4M+15.2% | $58.49M+8.6% | $53.87M-24.5% | $71.34M+20.8% | ||
| -$5.37M+27.6% | -$7.42M-3.0% | -$7.21M+17.2% | -$8.7M-1,355% | -$598K+93.4% | ||
| —— | $59.98M+16.9% | $51.29M+13.5% | $45.17M-36.1% | $70.74M+41.7% | ||
| —— | $15.24M+20.9% | $12.6M+13.1% | $11.14M-12.7% | $12.76M+2.7% | ||
| —— | $44.74M+15.7% | $38.68M+13.7% | $34.03M-41.3% | $57.98M+54.6% | ||
| —— | $0.95+17.3% | $0.81+15.7% | $0.70-40.2% | $1.17+58.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.